HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1284
https://www.valueinhealthjournal.com/article/S1098-3015(22)03489-1/fulltext
Title :
HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03489-1&doi=10.1016/j.jval.2022.09.1284
First page :
Section Title :
Open access? :
No
Section Order :
10834